Covid-19 O’tkazgan Komorbid Holatdagi Bemorlarda Surunkali Buyrak Kasalligining Kechishining Prognostik Ahamiyati
Keywords:
surunkali buyrak kasalligi, koptokchalar filtratsiya tezligiAbstract
Koronavirus infeksiyasi (COVID-19) jiddiy tibbiy va ijtimoiy muammodir. COVID-19 bilan kasallangan bemorlarni davolashda ma'lum muvaffaqiyatlarga erishilganiga qaramay, yondosh patologiya va asosoiy kasallik kechishida o’ziga xavf guruhiga kiradigan surunkali buyrak kasalligi (SBK) bilan og'rigan, bemorlarda maxsus klinik va tashkiliy yondashuvlarni ishlab chiqish zarurati mavjud. Tadqiqotimizning uchun olingan bemorlarning o’rtacha yoshi 68 yosh bo'lib, ularning 59 foizi erkaklar edi. Ushbu tadqiqot natijalari shuni ko'rsatdiki, umumiy aholi bilan solishtirganda, SBK bilan kasallangan bemorlarda COVID-19 og'irroq kechadi va o'lim darajasi yuqoriroqdir. Tadqiqotlar shuni ko’rsatadiku , SBK ning so'nggi bosqichining yuzaga kelishi va KFT sezilarli pasayishi o'pkaning shikastlanish hajmi bilan bog'liq emas.
References
Hardenberg J. B., Luft F. C. Covid-19, ACE2 and the kidney. Acta Physiol (Oxf). 2020. 238-239(1): e13539. doi:10.1111/apha.13539
Tomilina N. A. et al. Covid-19: connection with kidney pathology. Literature review. Nephrology and dialysis. 2021. 23(2): 147–236. Russian (Tomilina N.A. et al. Covid-19: connection with kidney pathology. Literature review. Nephrology and dialysis. 2021. 23(2): 147–236). doi: 10.28996/2618-9801-2021-2-147-159
Luis D’Marco1 , Marı´a Jesu´ s Puchades1 , Marı´a Romero-Parra1 , Elena Gimenez-Civera1 , Marı´a Jose´ Soler 2 , Alberto Ortiz3 and Jose´ Luis Gorriz 1. Coronavirus disease 2019 in chronic kidney disease. Clinical Kidney Journal, 2020, vol. 13, no. 3, str.297
Oyelade, T. Prognosis of COVID-19 in Patients with Liver and Kidney Diseases: An Early Systematic Review and Meta- Analysis / T. Oyelade, J. Alqahtani, G. Canciani // Trop. Med. Infect. Dis. – 2020 May. – Vol. 5, N. 2. – P. 80.
COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup / M. K. Nadim [et al.] // Nat. Rev. Nephrol. – 2020 Dec. – Vol. 16. – P. 747–764.
COVID-19 and Older Adults: What We Know / Z. Shahid [et al.] // J. Am. Geriatr. Soc. – 2020 May. – Vol. 68, N 5. – P. 926–929.
Comorbid Chronic Diseases and Acute Organ Injuries Are Strongly Correlated with Disease Severity and Mortality among COVID-19 Patients: A Systemic Review and Meta- Analysis / X. Wang [et al.] // Research (Wash D C). – 2020 Apr. – Vol. 2020. – 2020:2402961.
Henry, B. M. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection / B. M. Henry, G. Lippi // Int. Urol. Nephrol. – 2020. – Vol. 52, N 6.– P. 1193–1194.
International Society of Nephrology (ISN) [Electronic resource]. – Mode of access: https://www.theisn.org/covid-19.– Date of access: 22.01.2021.
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus / W. Li [et al.] // Nature. – 2003. – Vol. 426. – P. 450–454.
Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection / X. Zou [et al.] // Front Med. – 2020 Apr. – Vol. 14, N 2. – P. 185–192.
COVID-19: A Multidisciplinary Review / N. Chams [et al.] // Front. Public. Health. – 2020 Jul. – Vol. 8. – P. 383.
Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg9 bradykinin/BKB1R axis and facilitates LPS- induced neutrophil infiltration / C. P. Sodhi [et al.] // Am. J. Physiol. Lung. Cell. Mol. Physiol. – 2018 Jan. – Vol. 314, N 1. – P. L17–L31.
Angiotensin II induces kidney inflammatory injury and fibrosis through binding to yeloid differentiation protein-2 (MD2) / Z. Xu [et al.] // Sci. Rep. – 2017 Mar. – Vol. 7. – 44911.
Kinins and Cytokines in COVID-19: A Comprehensive Pathophysiological Approach / van de Veerdonk F. [et al.]. – (Preprints 2020040023). Pecly I. M. D. et al. COVID-19 and chronic kidney disease: a comprehensive review. J Bras Nefrol. 2021. 43(3): 383–399. doi: 10.1590/2175-8239-JBN-2020-0203.
Wu H., Huang J. Drug-Induced Nephrotoxicity: Pathogenic Mechanisms, Biomarkers and Prevention Strategies. Curr Drug Metab. 2018. 19(7): 559–567. doi: 10.2174/13892002186 66171108154419.
Аляви, А. Л., Турсунова, Л. Д., Бувамухамедова, Н. Т., & Жуманазаров, С. Б. (2021). Течение сердечно-сосудистых заболеваний у больных COVID-19. Студенческий вестник, (17-4), 38-41.
Мирзаева, Г. П., & Турсунова, Л. Д. (2019). НЕКОТОРЫЕ ПОКАЗАТЕЛИ СУТОЧНОГО МОНИТОРИРОВАНИЯ АРТЕРИАЛЬНОГО ДАВЛЕНИЯ У БОЛЬНЫХ С МЕТАБОЛИЧЕСКИМ СИНДРОМОМ. In Противоречия современной кардиологии: спорные и нерешенные вопросы (pp. 40-40).
Jumanazarov, S., Jabbarov, O., Umarova, Z., Tursunova, L., & Mirzayeva, G. (2022). Factors affecting platelet hemostasis and resistance to curantil in patients with chronic kidney disease.
Турсунова, Л. Д., Жаббаров, О. О., Мирзаева, Г. П., Жуманазаров, С. Б., & Хужаниязова, Н. К. (2022). Кардиоренал синдромда ангиотензин-неприлизин рецепторлари ингибиторларининг буйрак функционал холатига таъсири.
Tursunova, L. D., & Jabbarov, O. O. (2021). APPLICATION OF SAKABUTRIL/VALSARTAN IN PATIENTS WITH CHRONIC KIDNEY DISEASE WITH TYPE 2 DIABETES MELLITUS. Art of Medicine. International Medical Scientific Journal, 1(1).
